Tidsskriftet.no is a Norwegian website that offers a wide range of articles and publications covering various topics such as science, culture, politics, and more. With a focus on providing insightful and thought-provoking content, the website serves as a platform for intellectual discussions and exploration of ideas. Whether you are interested in staying updated on current affairs, delving into scientific research, or exploring cultural trends, Tidsskriftet.no offers a diverse collection of articles to cater to your interests. With its user-friendly interface and engaging content, the website aims to inform, inspire, and stimulate the minds of its readers.
Rank by traffic
In October 2024, tidsskriftet.no saw a decrease in search traffic, reaching 98K visits, which is a decrease of 59K visits compared to the previous month. The traffic value decreased to 9.1K, a reduction of 8.8K.
For tidsskriftet.no, Norway dominates traffic with 85K visits, a decrease of 48K from the previous month, making up 86.3% of the total traffic.
Location | Traffic | Share | |||||||
---|---|---|---|---|---|---|---|---|---|
85K | −48K | 86.3% | |||||||
8.2K | −7.3K | 8.3% | |||||||
1.7K | −1.4K | 1.7% | |||||||
922 | −1.1K | 0.9% | |||||||
666 | −431 | 0.6% | |||||||
tidsskriftet.no ranks #1 for "melatonin" in Norway and receives 1.2K monthly visits from this keyword alone, an increase of 462 from the previous month.
Keyword | Volume | Traffic | Position | ||||||
---|---|---|---|---|---|---|---|---|---|
melatonin | 19K | −1.0K | 1.2K | +462 | 7 → 5 | ||||
rastløse bein | 900 | 876 | +855 | 3 → 1 | |||||
artrose | 7.6K | −600 | 442 | +135 | 8 → 6 | ||||
hvilepuls | 3.5K | +100 | 437 | −360 | 1 → 4 | ||||
forstadier til kreft i bukspyttkjertelen | 1.0K | −100 | 407 | −76 | 1 | ||||
As of October 2024, tidsskriftet.no's Domain Rating is 75. tidsskriftet.no is linked by 6.6K websites, indicating an increase of 26 referring sites from the previous month.
Get an in-depth look at the organic search traffic and backlink profile of any website or URL.